128 related articles for article (PubMed ID: 24180734)
1. Postoperative hyperthermic syndrome following antiparkinsonian drugs withdrawal: the pitfall of enteral refeeding.
Casier I; Jeanjean A; Hantson P
Anaesth Intensive Care; 2013 Nov; 41(6):814-5. PubMed ID: 24180734
[No Abstract] [Full Text] [Related]
2. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
Young CC; Kaufman BS
J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
[TBL] [Abstract][Full Text] [Related]
3. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome after withdrawal of levopoda].
Cedeno-Veloz B; Areosa Sastre A
Rev Esp Geriatr Gerontol; 2018; 53(5):299-300. PubMed ID: 29628214
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome in advanced Parkinson's disease.
Gordon PH; Frucht SJ
Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome without neuroleptics.
Ong KC; Chew EL; Ong YY
Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
[TBL] [Abstract][Full Text] [Related]
7. Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
Stotz M; Thümmler D; Schürch M; Renggli JC; Urwyler A; Pargger H
Br J Anaesth; 2004 Dec; 93(6):868-71. PubMed ID: 15377584
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
Iwuagwu CU; Riley D; Bonoma RA
Am J Med; 2000 Apr; 108(6):517-8. PubMed ID: 10866587
[No Abstract] [Full Text] [Related]
9. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative respiratory failure resulting from perioperative withdrawal of antiparkinsonian medications].
Koganei H; Tanaka S; Iijima K; Horikawa Y; Tanaka O
Masui; 1999 Jan; 48(1):70-2. PubMed ID: 10036894
[TBL] [Abstract][Full Text] [Related]
11. A 77-year-old man with Parkinson's disease and hyperthermia.
Madigan EJ
J Emerg Nurs; 2008 Jun; 34(3):229-30. PubMed ID: 18558256
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome without neuroleptics.
Parsa MA; Rohr T; Ramirez LF; Meltzer HY
J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
[No Abstract] [Full Text] [Related]
13. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
Ladha SS; Walker R; Shill HA
Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
Hirschorn KA; Greenberg HS
Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
[No Abstract] [Full Text] [Related]
15. Malignant syndrome in Parkinson's disease: concept and review of the literature.
Mizuno Y; Takubo H; Mizuta E; Kuno S
Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome in parkinsonian patients: risk factors.
Kuno S; Mizuta E; Yamasaki S
Eur Neurol; 1997; 38 Suppl 2():56-9. PubMed ID: 9387804
[TBL] [Abstract][Full Text] [Related]
17. Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Linazasoro G; Van Blercom N; Castro A; Dapena MD
Neurology; 2004 Aug; 63(3):589-90. PubMed ID: 15304607
[No Abstract] [Full Text] [Related]
18. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
Rainer C; Scheinost NA; Lefeber EJ
Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
[TBL] [Abstract][Full Text] [Related]
19. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
Thomas A; Onofrj M
Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
[No Abstract] [Full Text] [Related]
20. The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
Li W; Saweris M; Madhira B
Am J Ther; 2018; 25(5):e606-e607. PubMed ID: 28731860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
